|
PMS2L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.25420007712762E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.15570031112134E-10 |
| Normal-vs-Stage2 |
3.680900E-03 |
| Normal-vs-Stage3 |
3.90550000006762E-07 |
| Normal-vs-Stage4 |
2.22320000187182E-08 |
| Stage1-vs-Stage2 |
2.087600E-01 |
| Stage1-vs-Stage3 |
9.046800E-01 |
| Stage1-vs-Stage4 |
2.263800E-01 |
| Stage2-vs-Stage3 |
2.702200E-01 |
| Stage2-vs-Stage4 |
5.043900E-02 |
| Stage3-vs-Stage4 |
3.138600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.88149545627448E-11 |
| Normal-vs-AfricanAmerican |
2.881500E-03 |
| Normal-vs-Asian |
6.47020000021925E-07 |
| Caucasian-vs-AfricanAmerican |
7.120000E-01 |
| Caucasian-vs-Asian |
8.923000E-01 |
| AfricanAmerican-vs-Asian |
7.702600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.92450533076772E-11 |
| Normal-vs-Female |
2.8425000131449E-09 |
| Male-vs-Female |
9.927900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.28919996479038E-09 |
| Normal-vs-Age(41-60Yrs) |
9.37929955924233E-10 |
| Normal-vs-Age(61-80Yrs) |
1.74160999999451E-05 |
| Normal-vs-Age(81-100Yrs) |
1.152450E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.705600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.142400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.879600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.437200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.434200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.404000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.635970E-03 |
| Classical-VS-Follicular |
1.283020E-01 |
| Classical-VS-Other |
3.686800E-01 |
| Classical-VS-Normal |
4.67579974738896E-10 |
| Tall-VS-Follicular |
4.623900E-04 |
| Tall-VS-Other |
6.472600E-01 |
| Tall-VS-Normal |
9.202416606513E-12 |
| Follicular-VS-Other |
2.678000E-01 |
| Follicular-VS-Normal |
4.076600E-03 |
| Other-VS-Normal |
1.595450E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.3963000001247E-07 |
| Normal-vs-N1 |
1.05669994976409E-09 |
| N0-vs-N1 |
1.099570E-02 |
|
|
